Follow on Google News News By Tag * Lyophilisation * Prefilled Syringes * Biopharmaceuticals * Monoclonal Antibodies * Insulins * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | The Lyophilisation for Pharmaceuticals Products and Services Market will reach $3.45bn in 2015By: Visiongain The growth in the lyophilisation for pharmaceuticals market (https://www.visiongain.com/ Amy To, pharmaceutical and medical devices analyst at visiongain explains: “There has been a fast growing demand for lyophilisation services over the last few years, with many CMOs expanding their freeze drying facilities as part of their growth strategy. There are new technologies that have emerged to improve the lyophilisation process such as process Analytical Technologies (PAT) and controlled nucleation techniques such as ICE Fog. These advances should optimise the freeze dry cycle to maximise process efficiency and thus reduce high running costs and product formulation challenges. On the other hand, there are competing technologies that will somewhat restrain growth in the lyophilisation products and services market. The most significant substitute technology is spray drying because it is much more of an economical process as compared to lyophilisation. However the process of spray drying is not suitable for many biopharmaceutical products and therefore lyophilisation will remain the preferred method over the forecast period.” Visiongain’s brand new 222 page report provides revenue forecasts to 2025 for the world lyophilisation for pharmaceuticals market and leading regional and national markets. It forecasts sales in the US, Japan, Germany, France, Italy, Spain, UK, China, India, Russia, Brazil, Turkey, Mexico and South Korea. The report also forecasts sales for the submarket cGMP lyophilisers, laboratory lyophilisers, lyophilisation services and forecasts for its most prominent pharmaceutical applications (monoclonal antibodies, insulin, interferons, other recombinant hormones, plasma and recombinant coagulation factors, other protein therapeutics, biosimilars and vaccines). It also includes three exclusive interviews with industry experts within the lyophilisation industry. Lyophilisation for Pharmaceuticals: For sample pages and further information concerning the visiongain Lyophilisation for Pharmaceuticals: For an executive summary please contact: Email: Sara Peerun on sara.peerun@ Tel: +44 (0) 20 7336 6100 Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail tosara.peerun@ About visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors. Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first portofcall for the business professional who needs independent, high quality, original analyses to inform their strategic decisions. End
Account Phone Number Disclaimer Report Abuse
|
|